An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumorMartin Gore, David M. Gershenson, Allan Hackshaw et al.|Gynecologic Oncology|2019Cited by 104
Multicentre trial of carboplatin/paclitaxel versus oxaliplatin/capecitabine, each with/without bevacizumab, as first line chemotherapy for patients with mucinous epithelial ovarian cancer (mEOC).Martin Gore, David M. Gershenson, Allan Hackshaw et al.|Journal of Clinical Oncology|2015Cited by 35
OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancerEleni Frangou, Sarah P. Blagden, Rosemary Lord et al.|Gynecologic Oncology|2021Cited by 22
OVPSYCH2: A randomised study of psychological support versus standard of care following chemotherapy for ovarian cancerSarah P. Blagden, L. Howells, Gianfilippo Bertelli et al.|Annals of Oncology|2018Cited by 1